Bridge Biotherapeutics Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bridge Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 416 KRW -3.03% Market Closed

Market Cap: ₩44.1B

B	Bridge Biotherapeutics Inc KOSDAQ:288330	KR
M	MGM Resorts International BMV:MGM	US

Profitability Summary

Bridge Biotherapeutics Inc's profitability score is 12/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-18%

Sustainable 3Y Average Gross Margin

21%

Negative Operating Margin

-818%

Negative 3Y Average Operating Margin

-409 928%

Operating Margin is Increasing

-1 797% > -818%

Negative Net Margin

-2 477%

Negative 3Y Average Net Margin

-459 948%

Declining Net Margin

-1 678% > -2 477%

Negative Free Cash Flow Margin

-4 205%

Negative 3Y Average Free Cash Flow Margin

-446 768%

Declining Free Cash Flow Margin

-1 541% > -4 205%

Negative ROE

-80%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-161%

ROIC is Increasing

-408% > -29%

View All

Hide

Collapse

12 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.